Essay About Drug Profile And Use Of Heat

Ketamine
Essay Preview: Ketamine
Report this essay
Drug Profile: KetamineNameInstitutionDrug Profile Check SheetName(s):Common Brand Name: Ketalar, Chemical Name Ketamine or 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone, Street Name(s): K, Super C, Cat Valium, Jet, Super acid Green, Puprle and Special K.Drug ClassificationClassified as a Psychotomimetic, Dissociative Anaesthetic, and a Hallucinogen (National Highway Traffic Safety Administration, n.d)MythosUsers engage in illegal activities, promotes illegal behavior, main cause for psychosis, can be mixed with alcohol safely, provides insight into the universe, cannot make one sick, addicted users do not need treatment. Other myths include; it is safe, natural and Non addictive (Lockwood, 2006).HistoryKetamine has a history of human usage as a hallucinogen. The interest in the drug developed gradually from Ancient Greece attributed by the visions and omens that were evident after the inhalation of a dissociative anesthetic, nitrous oxide   (TD Consultancy, 2017). The drug has seen popularity as an illicit drug in China (BBC News, 2017) and Egypt (Samy, 2015).ChemistryKetamine is synthesized from the reaction between cyclopentyl Grignard and o-chlorobenzonitrile, which produces o-chlorophenyl-cyclopentyl ketone. This was then brominated and then reacted with methylamine forming 1-Hydroxycyclopentyl-(o-chlorophenyl)-ketone-N-methylimine. Heating the product forms Ketamine through novel alpha-hydroxyimine rearrangement.Ketamine can achieve purification by using Isopropyl alcoholUndergoes degradation by the use of heat or treatment with an acid or baseSynthetic Starting reagents used to synthesize Ketamine are cyclopentyl Grignard and o-chlorobenzonitrileMechanism of action (MOA)Ketamine undergoes interaction with N-methyl-D-aspartate (NMDA) receptors, monoaminergic receptors, opioid receptors, muscarinic receptors and voltage sensitive Ca ion channels. Does not interact with GABA receptors.Neurotransmitter system(s) affectedDopamine, Noradrenaline, glutamate, GABA, serotonin, Ach, Histamine, Glycine &>200 othersDisorder used to treat OR Addictive liabilitySchizophrenia, depression, bipolar, PTSD, Obsessive Compulsive Disorder, fibromyalgia, neuropathic syndromes, severe anxiety and drug addictionEfficacy (if therapeutic)Low, moderate or high depending on the therapy employedPharmacokineticsThe bioavailability of ketamine after different dosages in various sites of action are as follows: an intramuscular 93%, intranasal 25-50%, and oral 20±7%.  The drug is rapidly distributed into the brain and other highly perfused tissues. Ketamine is 12% bound in plasma (plasma’s half life is 2.3 ± 0.5 hours. Oral administration results in peak concentrations of ketamine that is lower. SolubilityKetamine is lipophilic.Common Route(s) of administrationIntravenous, intranasal, sublingual, intramuscular, oral and rectal meansUsual dose-range (by route)Intranasal dosage is 10-250mg/kg between 5 and 15mins. Oral is 40 to 500+mg/kg between 5 and 20mins. Rectal is 40-500+mg/kg between 5 and 20mins. IM is 10-200mg between 1 and 5mins. I.V is 1- 4.5mg/kg between 1 and 4mins. Metabolism/ExcretionUndergoes first pass metabolism upon oral administration. The drug then goes to the liver where biotransformation to norketamine and dehydronorketamine takes place using CYP3A4, CYP2B6, and CYP2C9.Major effects (desired)Pain management and dissociative aesthetic state.Side-effects (undesirable)Bluish skin,  blurry vision, difficulty breathing, convulsions, itching, urination urge, unusual weakness, unusual senses, loss of consciousness, deathLethality (toxicity) methodSuffocation (loss of consciousness), liver damage (evidenced by biliary and hepatic complications)Usual Cause of deathOverdose or chronic use, resulting in respiratory complications which lead to death.ToleranceCellular tolerance where damaging effects evident on brain cells that secrete neurotransmitters. Metabolic tolerance in the sense that cell structures break thus becoming less sensitive to the effects of ketamine. Behavioral tolerance in the form of alterations of sensory perceptions resulting in the ingestion of larger ketamine doses to maintain hallucinogenic effect.Physical dependenceCan be low, moderate or high depending on the frequent of usage of ketamine.Psychological dependenceCraving for the drug may be low, moderate or high depending on the frequency of usage of the drugWithdrawal symptomsParanoia, depression, emotional and physical imbalance in nature. Actual symptoms may include; muscle cramps, headache, tremors, rapid breathing, loss of hearing, double vision, accelerated heart beat and loss of coordination and motor ability.Psychological effects on consciousnessHallucinatory effects occur where a lessening, or heighten of confusion may be experienced.UsesMedical, hallucinogen or a Psychotomimetic agentBehavioral testsActivity (swimming and maze tests), Analgesia, SD, ICSS, CPP Assessment instrumentsRating scales, which take note of psychiatric, visual and mood measurements.